世界の呼吸器感染症診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Respiratory Infection Diagnostic Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5333 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、呼吸器感染症診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（微生物、PCR、NGS、イムノアッセイ）、用途別市場規模（病院研究室、外来研究室）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・呼吸器感染症診断の市場動向 ・企業の競争状況、市場シェア ・呼吸器感染症診断の種類別市場規模と予測2016-2027（微生物、PCR、NGS、イムノアッセイ） ・呼吸器感染症診断の用途別市場規模と予測2016-2027（病院研究室、外来研究室） ・呼吸器感染症診断の北米市場規模2016-2027（アメリカ、カナダ） ・呼吸器感染症診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・呼吸器感染症診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・呼吸器感染症診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・呼吸器感染症診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Ador Diagnostics、BD Diagnostics、Co-Diagnostics、Diagenode Diagnostics、GenePOC Diagnostics、Veradus Labs、Immunexpress、Janssen Diagnostics、Lumos Diagnostics、Oxford Nanopore、Prominex、Roche Molecular Diagnostics、SkylineDx、T2 Biosystems） ・結論

Market Analysis and Insights: Global Respiratory Infection Diagnostic Market
The global Respiratory Infection Diagnostic market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Respiratory Infection Diagnostic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Respiratory Infection Diagnostic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Respiratory Infection Diagnostic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Respiratory Infection Diagnostic market.

Global Respiratory Infection Diagnostic Scope and Market Size
Respiratory Infection Diagnostic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Respiratory Infection Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Microbiology
PCR
NGS
Immunoassay

Segment by Application
Hospital Lab
Outpatient Lab

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Ador Diagnostics
BD Diagnostics
Co-Diagnostics
Diagenode Diagnostics
GenePOC Diagnostics
Veradus Labs
Immunexpress
Janssen Diagnostics
Lumos Diagnostics
Oxford Nanopore
Prominex
Roche Molecular Diagnostics
SkylineDx
T2 Biosystems

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Respiratory Infection Diagnostic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Microbiology
1.2.3 PCR
1.2.4 NGS
1.2.5 Immunoassay
1.3 Market by Application
1.3.1 Global Respiratory Infection Diagnostic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Lab
1.3.3 Outpatient Lab
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Respiratory Infection Diagnostic Market Perspective (2016-2027)
2.2 Respiratory Infection Diagnostic Growth Trends by Regions
2.2.1 Respiratory Infection Diagnostic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Respiratory Infection Diagnostic Historic Market Share by Regions (2016-2021)
2.2.3 Respiratory Infection Diagnostic Forecasted Market Size by Regions (2022-2027)
2.3 Respiratory Infection Diagnostic Industry Dynamic
2.3.1 Respiratory Infection Diagnostic Market Trends
2.3.2 Respiratory Infection Diagnostic Market Drivers
2.3.3 Respiratory Infection Diagnostic Market Challenges
2.3.4 Respiratory Infection Diagnostic Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Respiratory Infection Diagnostic Players by Revenue
3.1.1 Global Top Respiratory Infection Diagnostic Players by Revenue (2016-2021)
3.1.2 Global Respiratory Infection Diagnostic Revenue Market Share by Players (2016-2021)
3.2 Global Respiratory Infection Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Respiratory Infection Diagnostic Revenue
3.4 Global Respiratory Infection Diagnostic Market Concentration Ratio
3.4.1 Global Respiratory Infection Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Respiratory Infection Diagnostic Revenue in 2020
3.5 Respiratory Infection Diagnostic Key Players Head office and Area Served
3.6 Key Players Respiratory Infection Diagnostic Product Solution and Service
3.7 Date of Enter into Respiratory Infection Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Respiratory Infection Diagnostic Breakdown Data by Type
4.1 Global Respiratory Infection Diagnostic Historic Market Size by Type (2016-2021)
4.2 Global Respiratory Infection Diagnostic Forecasted Market Size by Type (2022-2027)

5 Respiratory Infection Diagnostic Breakdown Data by Application
5.1 Global Respiratory Infection Diagnostic Historic Market Size by Application (2016-2021)
5.2 Global Respiratory Infection Diagnostic Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Respiratory Infection Diagnostic Market Size (2016-2027)
6.2 North America Respiratory Infection Diagnostic Market Size by Type
6.2.1 North America Respiratory Infection Diagnostic Market Size by Type (2016-2021)
6.2.2 North America Respiratory Infection Diagnostic Market Size by Type (2022-2027)
6.2.3 North America Respiratory Infection Diagnostic Market Size by Type (2016-2027)
6.3 North America Respiratory Infection Diagnostic Market Size by Application
6.3.1 North America Respiratory Infection Diagnostic Market Size by Application (2016-2021)
6.3.2 North America Respiratory Infection Diagnostic Market Size by Application (2022-2027)
6.3.3 North America Respiratory Infection Diagnostic Market Size by Application (2016-2027)
6.4 North America Respiratory Infection Diagnostic Market Size by Country
6.4.1 North America Respiratory Infection Diagnostic Market Size by Country (2016-2021)
6.4.2 North America Respiratory Infection Diagnostic Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Respiratory Infection Diagnostic Market Size (2016-2027)
7.2 Europe Respiratory Infection Diagnostic Market Size by Type
7.2.1 Europe Respiratory Infection Diagnostic Market Size by Type (2016-2021)
7.2.2 Europe Respiratory Infection Diagnostic Market Size by Type (2022-2027)
7.2.3 Europe Respiratory Infection Diagnostic Market Size by Type (2016-2027)
7.3 Europe Respiratory Infection Diagnostic Market Size by Application
7.3.1 Europe Respiratory Infection Diagnostic Market Size by Application (2016-2021)
7.3.2 Europe Respiratory Infection Diagnostic Market Size by Application (2022-2027)
7.3.3 Europe Respiratory Infection Diagnostic Market Size by Application (2016-2027)
7.4 Europe Respiratory Infection Diagnostic Market Size by Country
7.4.1 Europe Respiratory Infection Diagnostic Market Size by Country (2016-2021)
7.4.2 Europe Respiratory Infection Diagnostic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Respiratory Infection Diagnostic Market Size (2016-2027)
8.2 Asia-Pacific Respiratory Infection Diagnostic Market Size by Type
8.2.1 Asia-Pacific Respiratory Infection Diagnostic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Respiratory Infection Diagnostic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Respiratory Infection Diagnostic Market Size by Type (2016-2027)
8.3 Asia-Pacific Respiratory Infection Diagnostic Market Size by Application
8.3.1 Asia-Pacific Respiratory Infection Diagnostic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Respiratory Infection Diagnostic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Respiratory Infection Diagnostic Market Size by Application (2016-2027)
8.4 Asia-Pacific Respiratory Infection Diagnostic Market Size by Region
8.4.1 Asia-Pacific Respiratory Infection Diagnostic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Respiratory Infection Diagnostic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Respiratory Infection Diagnostic Market Size (2016-2027)
9.2 Latin America Respiratory Infection Diagnostic Market Size by Type
9.2.1 Latin America Respiratory Infection Diagnostic Market Size by Type (2016-2021)
9.2.2 Latin America Respiratory Infection Diagnostic Market Size by Type (2022-2027)
9.2.3 Latin America Respiratory Infection Diagnostic Market Size by Type (2016-2027)
9.3 Latin America Respiratory Infection Diagnostic Market Size by Application
9.3.1 Latin America Respiratory Infection Diagnostic Market Size by Application (2016-2021)
9.3.2 Latin America Respiratory Infection Diagnostic Market Size by Application (2022-2027)
9.3.3 Latin America Respiratory Infection Diagnostic Market Size by Application (2016-2027)
9.4 Latin America Respiratory Infection Diagnostic Market Size by Country
9.4.1 Latin America Respiratory Infection Diagnostic Market Size by Country (2016-2021)
9.4.2 Latin America Respiratory Infection Diagnostic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Respiratory Infection Diagnostic Market Size (2016-2027)
10.2 Middle East & Africa Respiratory Infection Diagnostic Market Size by Type
10.2.1 Middle East & Africa Respiratory Infection Diagnostic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Respiratory Infection Diagnostic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Respiratory Infection Diagnostic Market Size by Type (2016-2027)
10.3 Middle East & Africa Respiratory Infection Diagnostic Market Size by Application
10.3.1 Middle East & Africa Respiratory Infection Diagnostic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Respiratory Infection Diagnostic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Respiratory Infection Diagnostic Market Size by Application (2016-2027)
10.4 Middle East & Africa Respiratory Infection Diagnostic Market Size by Country
10.4.1 Middle East & Africa Respiratory Infection Diagnostic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Respiratory Infection Diagnostic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Ador Diagnostics
11.1.1 Ador Diagnostics Company Details
11.1.2 Ador Diagnostics Business Overview
11.1.3 Ador Diagnostics Respiratory Infection Diagnostic Introduction
11.1.4 Ador Diagnostics Revenue in Respiratory Infection Diagnostic Business (2016-2021)
11.1.5 Ador Diagnostics Recent Development
11.2 BD Diagnostics
11.2.1 BD Diagnostics Company Details
11.2.2 BD Diagnostics Business Overview
11.2.3 BD Diagnostics Respiratory Infection Diagnostic Introduction
11.2.4 BD Diagnostics Revenue in Respiratory Infection Diagnostic Business (2016-2021)
11.2.5 BD Diagnostics Recent Development
11.3 Co-Diagnostics
11.3.1 Co-Diagnostics Company Details
11.3.2 Co-Diagnostics Business Overview
11.3.3 Co-Diagnostics Respiratory Infection Diagnostic Introduction
11.3.4 Co-Diagnostics Revenue in Respiratory Infection Diagnostic Business (2016-2021)
11.3.5 Co-Diagnostics Recent Development
11.4 Diagenode Diagnostics
11.4.1 Diagenode Diagnostics Company Details
11.4.2 Diagenode Diagnostics Business Overview
11.4.3 Diagenode Diagnostics Respiratory Infection Diagnostic Introduction
11.4.4 Diagenode Diagnostics Revenue in Respiratory Infection Diagnostic Business (2016-2021)
11.4.5 Diagenode Diagnostics Recent Development
11.5 GenePOC Diagnostics
11.5.1 GenePOC Diagnostics Company Details
11.5.2 GenePOC Diagnostics Business Overview
11.5.3 GenePOC Diagnostics Respiratory Infection Diagnostic Introduction
11.5.4 GenePOC Diagnostics Revenue in Respiratory Infection Diagnostic Business (2016-2021)
11.5.5 GenePOC Diagnostics Recent Development
11.6 Veradus Labs
11.6.1 Veradus Labs Company Details
11.6.2 Veradus Labs Business Overview
11.6.3 Veradus Labs Respiratory Infection Diagnostic Introduction
11.6.4 Veradus Labs Revenue in Respiratory Infection Diagnostic Business (2016-2021)
11.6.5 Veradus Labs Recent Development
11.7 Immunexpress
11.7.1 Immunexpress Company Details
11.7.2 Immunexpress Business Overview
11.7.3 Immunexpress Respiratory Infection Diagnostic Introduction
11.7.4 Immunexpress Revenue in Respiratory Infection Diagnostic Business (2016-2021)
11.7.5 Immunexpress Recent Development
11.8 Janssen Diagnostics
11.8.1 Janssen Diagnostics Company Details
11.8.2 Janssen Diagnostics Business Overview
11.8.3 Janssen Diagnostics Respiratory Infection Diagnostic Introduction
11.8.4 Janssen Diagnostics Revenue in Respiratory Infection Diagnostic Business (2016-2021)
11.8.5 Janssen Diagnostics Recent Development
11.9 Lumos Diagnostics
11.9.1 Lumos Diagnostics Company Details
11.9.2 Lumos Diagnostics Business Overview
11.9.3 Lumos Diagnostics Respiratory Infection Diagnostic Introduction
11.9.4 Lumos Diagnostics Revenue in Respiratory Infection Diagnostic Business (2016-2021)
11.9.5 Lumos Diagnostics Recent Development
11.10 Oxford Nanopore
11.10.1 Oxford Nanopore Company Details
11.10.2 Oxford Nanopore Business Overview
11.10.3 Oxford Nanopore Respiratory Infection Diagnostic Introduction
11.10.4 Oxford Nanopore Revenue in Respiratory Infection Diagnostic Business (2016-2021)
11.10.5 Oxford Nanopore Recent Development
11.11 Prominex
11.11.1 Prominex Company Details
11.11.2 Prominex Business Overview
11.11.3 Prominex Respiratory Infection Diagnostic Introduction
11.11.4 Prominex Revenue in Respiratory Infection Diagnostic Business (2016-2021)
11.11.5 Prominex Recent Development
11.12 Roche Molecular Diagnostics
11.12.1 Roche Molecular Diagnostics Company Details
11.12.2 Roche Molecular Diagnostics Business Overview
11.12.3 Roche Molecular Diagnostics Respiratory Infection Diagnostic Introduction
11.12.4 Roche Molecular Diagnostics Revenue in Respiratory Infection Diagnostic Business (2016-2021)
11.12.5 Roche Molecular Diagnostics Recent Development
11.13 SkylineDx
11.13.1 SkylineDx Company Details
11.13.2 SkylineDx Business Overview
11.13.3 SkylineDx Respiratory Infection Diagnostic Introduction
11.13.4 SkylineDx Revenue in Respiratory Infection Diagnostic Business (2016-2021)
11.13.5 SkylineDx Recent Development
11.14 T2 Biosystems
11.14.1 T2 Biosystems Company Details
11.14.2 T2 Biosystems Business Overview
11.14.3 T2 Biosystems Respiratory Infection Diagnostic Introduction
11.14.4 T2 Biosystems Revenue in Respiratory Infection Diagnostic Business (2016-2021)
11.14.5 T2 Biosystems Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Respiratory Infection Diagnostic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Microbiology
Table 3. Key Players of PCR
Table 4. Key Players of NGS
Table 5. Key Players of Immunoassay
Table 6. Global Respiratory Infection Diagnostic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Respiratory Infection Diagnostic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Respiratory Infection Diagnostic Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Respiratory Infection Diagnostic Market Share by Regions (2016-2021)
Table 10. Global Respiratory Infection Diagnostic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Respiratory Infection Diagnostic Market Share by Regions (2022-2027)
Table 12. Respiratory Infection Diagnostic Market Trends
Table 13. Respiratory Infection Diagnostic Market Drivers
Table 14. Respiratory Infection Diagnostic Market Challenges
Table 15. Respiratory Infection Diagnostic Market Restraints
Table 16. Global Respiratory Infection Diagnostic Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Respiratory Infection Diagnostic Market Share by Players (2016-2021)
Table 18. Global Top Respiratory Infection Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Infection Diagnostic as of 2020)
Table 19. Ranking of Global Top Respiratory Infection Diagnostic Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Respiratory Infection Diagnostic Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Respiratory Infection Diagnostic Product Solution and Service
Table 23. Date of Enter into Respiratory Infection Diagnostic Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Respiratory Infection Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Respiratory Infection Diagnostic Revenue Market Share by Type (2016-2021)
Table 27. Global Respiratory Infection Diagnostic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Respiratory Infection Diagnostic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Respiratory Infection Diagnostic Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Respiratory Infection Diagnostic Revenue Market Share by Application (2016-2021)
Table 31. Global Respiratory Infection Diagnostic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Respiratory Infection Diagnostic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Respiratory Infection Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Respiratory Infection Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Respiratory Infection Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Respiratory Infection Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Respiratory Infection Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Respiratory Infection Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Respiratory Infection Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Respiratory Infection Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Respiratory Infection Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Respiratory Infection Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Respiratory Infection Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Respiratory Infection Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Respiratory Infection Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Respiratory Infection Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Respiratory Infection Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Respiratory Infection Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Respiratory Infection Diagnostic Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Respiratory Infection Diagnostic Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Respiratory Infection Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Respiratory Infection Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Respiratory Infection Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Respiratory Infection Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Respiratory Infection Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Respiratory Infection Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Respiratory Infection Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Respiratory Infection Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Respiratory Infection Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Respiratory Infection Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Respiratory Infection Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Respiratory Infection Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 63. Ador Diagnostics Company Details
Table 64. Ador Diagnostics Business Overview
Table 65. Ador Diagnostics Respiratory Infection Diagnostic Product
Table 66. Ador Diagnostics Revenue in Respiratory Infection Diagnostic Business (2016-2021) & (US$ Million)
Table 67. Ador Diagnostics Recent Development
Table 68. BD Diagnostics Company Details
Table 69. BD Diagnostics Business Overview
Table 70. BD Diagnostics Respiratory Infection Diagnostic Product
Table 71. BD Diagnostics Revenue in Respiratory Infection Diagnostic Business (2016-2021) & (US$ Million)
Table 72. BD Diagnostics Recent Development
Table 73. Co-Diagnostics Company Details
Table 74. Co-Diagnostics Business Overview
Table 75. Co-Diagnostics Respiratory Infection Diagnostic Product
Table 76. Co-Diagnostics Revenue in Respiratory Infection Diagnostic Business (2016-2021) & (US$ Million)
Table 77. Co-Diagnostics Recent Development
Table 78. Diagenode Diagnostics Company Details
Table 79. Diagenode Diagnostics Business Overview
Table 80. Diagenode Diagnostics Respiratory Infection Diagnostic Product
Table 81. Diagenode Diagnostics Revenue in Respiratory Infection Diagnostic Business (2016-2021) & (US$ Million)
Table 82. Diagenode Diagnostics Recent Development
Table 83. GenePOC Diagnostics Company Details
Table 84. GenePOC Diagnostics Business Overview
Table 85. GenePOC Diagnostics Respiratory Infection Diagnostic Product
Table 86. GenePOC Diagnostics Revenue in Respiratory Infection Diagnostic Business (2016-2021) & (US$ Million)
Table 87. GenePOC Diagnostics Recent Development
Table 88. Veradus Labs Company Details
Table 89. Veradus Labs Business Overview
Table 90. Veradus Labs Respiratory Infection Diagnostic Product
Table 91. Veradus Labs Revenue in Respiratory Infection Diagnostic Business (2016-2021) & (US$ Million)
Table 92. Veradus Labs Recent Development
Table 93. Immunexpress Company Details
Table 94. Immunexpress Business Overview
Table 95. Immunexpress Respiratory Infection Diagnostic Product
Table 96. Immunexpress Revenue in Respiratory Infection Diagnostic Business (2016-2021) & (US$ Million)
Table 97. Immunexpress Recent Development
Table 98. Janssen Diagnostics Company Details
Table 99. Janssen Diagnostics Business Overview
Table 100. Janssen Diagnostics Revenue in Respiratory Infection Diagnostic Business (2016-2021) & (US$ Million)
Table 101. Janssen Diagnostics Recent Development
Table 102. Lumos Diagnostics Company Details
Table 103. Lumos Diagnostics Business Overview
Table 104. Lumos Diagnostics Respiratory Infection Diagnostic Product
Table 105. Lumos Diagnostics Revenue in Respiratory Infection Diagnostic Business (2016-2021) & (US$ Million)
Table 106. Lumos Diagnostics Recent Development
Table 107. Oxford Nanopore Company Details
Table 108. Oxford Nanopore Business Overview
Table 109. Oxford Nanopore Respiratory Infection Diagnostic Product
Table 110. Oxford Nanopore Revenue in Respiratory Infection Diagnostic Business (2016-2021) & (US$ Million)
Table 111. Oxford Nanopore Recent Development
Table 112. Prominex Company Details
Table 113. Prominex Business Overview
Table 114. Prominex Respiratory Infection Diagnostic Product
Table 115. Prominex Revenue in Respiratory Infection Diagnostic Business (2016-2021) & (US$ Million)
Table 116. Prominex Recent Development
Table 117. Roche Molecular Diagnostics Company Details
Table 118. Roche Molecular Diagnostics Business Overview
Table 119. Roche Molecular Diagnostics Respiratory Infection Diagnostic Product
Table 120. Roche Molecular Diagnostics Revenue in Respiratory Infection Diagnostic Business (2016-2021) & (US$ Million)
Table 121. Roche Molecular Diagnostics Recent Development
Table 122. SkylineDx Company Details
Table 123. SkylineDx Business Overview
Table 124. SkylineDx Respiratory Infection Diagnostic Product
Table 125. SkylineDx Revenue in Respiratory Infection Diagnostic Business (2016-2021) & (US$ Million)
Table 126. SkylineDx Recent Development
Table 127. T2 Biosystems Company Details
Table 128. T2 Biosystems Business Overview
Table 129. T2 Biosystems Respiratory Infection Diagnostic Product
Table 130. T2 Biosystems Revenue in Respiratory Infection Diagnostic Business (2016-2021) & (US$ Million)
Table 131. T2 Biosystems Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Respiratory Infection Diagnostic Market Share by Type: 2020 VS 2027
Figure 2. Microbiology Features
Figure 3. PCR Features
Figure 4. NGS Features
Figure 5. Immunoassay Features
Figure 6. Global Respiratory Infection Diagnostic Market Share by Application: 2020 VS 2027
Figure 7. Hospital Lab Case Studies
Figure 8. Outpatient Lab Case Studies
Figure 9. Respiratory Infection Diagnostic Report Years Considered
Figure 10. Global Respiratory Infection Diagnostic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Respiratory Infection Diagnostic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Respiratory Infection Diagnostic Market Share by Regions: 2020 VS 2027
Figure 13. Global Respiratory Infection Diagnostic Market Share by Regions (2022-2027)
Figure 14. Global Respiratory Infection Diagnostic Market Share by Players in 2020
Figure 15. Global Top Respiratory Infection Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Infection Diagnostic as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Respiratory Infection Diagnostic Revenue in 2020
Figure 17. Global Respiratory Infection Diagnostic Revenue Market Share by Type (2016-2021)
Figure 18. Global Respiratory Infection Diagnostic Revenue Market Share by Type (2022-2027)
Figure 19. North America Respiratory Infection Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Respiratory Infection Diagnostic Market Share by Type (2016-2027)
Figure 21. North America Respiratory Infection Diagnostic Market Share by Application (2016-2027)
Figure 22. North America Respiratory Infection Diagnostic Market Share by Country (2016-2027)
Figure 23. United States Respiratory Infection Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Respiratory Infection Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Respiratory Infection Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Respiratory Infection Diagnostic Market Share by Type (2016-2027)
Figure 27. Europe Respiratory Infection Diagnostic Market Share by Application (2016-2027)
Figure 28. Europe Respiratory Infection Diagnostic Market Share by Country (2016-2027)
Figure 29. Germany Respiratory Infection Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Respiratory Infection Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Respiratory Infection Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Respiratory Infection Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Respiratory Infection Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Respiratory Infection Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Respiratory Infection Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Respiratory Infection Diagnostic Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Respiratory Infection Diagnostic Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Respiratory Infection Diagnostic Market Share by Region (2016-2027)
Figure 39. China Respiratory Infection Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Respiratory Infection Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Respiratory Infection Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Respiratory Infection Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Respiratory Infection Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Respiratory Infection Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Respiratory Infection Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Respiratory Infection Diagnostic Market Share by Type (2016-2027)
Figure 47. Latin America Respiratory Infection Diagnostic Market Share by Application (2016-2027)
Figure 48. Latin America Respiratory Infection Diagnostic Market Share by Country (2016-2027)
Figure 49. Mexico Respiratory Infection Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Respiratory Infection Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Respiratory Infection Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Respiratory Infection Diagnostic Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Respiratory Infection Diagnostic Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Respiratory Infection Diagnostic Market Share by Country (2016-2027)
Figure 55. Turkey Respiratory Infection Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Respiratory Infection Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Respiratory Infection Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Ador Diagnostics Revenue Growth Rate in Respiratory Infection Diagnostic Business (2016-2021)
Figure 59. BD Diagnostics Revenue Growth Rate in Respiratory Infection Diagnostic Business (2016-2021)
Figure 60. Co-Diagnostics Revenue Growth Rate in Respiratory Infection Diagnostic Business (2016-2021)
Figure 61. Diagenode Diagnostics Revenue Growth Rate in Respiratory Infection Diagnostic Business (2016-2021)
Figure 62. GenePOC Diagnostics Revenue Growth Rate in Respiratory Infection Diagnostic Business (2016-2021)
Figure 63. Veradus Labs Revenue Growth Rate in Respiratory Infection Diagnostic Business (2016-2021)
Figure 64. Immunexpress Revenue Growth Rate in Respiratory Infection Diagnostic Business (2016-2021)
Figure 65. Janssen Diagnostics Revenue Growth Rate in Respiratory Infection Diagnostic Business (2016-2021)
Figure 66. Lumos Diagnostics Revenue Growth Rate in Respiratory Infection Diagnostic Business (2016-2021)
Figure 67. Oxford Nanopore Revenue Growth Rate in Respiratory Infection Diagnostic Business (2016-2021)
Figure 68. Prominex Revenue Growth Rate in Respiratory Infection Diagnostic Business (2016-2021)
Figure 69. Roche Molecular Diagnostics Revenue Growth Rate in Respiratory Infection Diagnostic Business (2016-2021)
Figure 70. SkylineDx Revenue Growth Rate in Respiratory Infection Diagnostic Business (2016-2021)
Figure 71. T2 Biosystems Revenue Growth Rate in Respiratory Infection Diagnostic Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

---